| Cat. No. |
Product Name |
Information |
| PC-24923 |
BPR2-D2
Antiviral
|
BPR2-D2 is a small molecule inhibitor against influenza virus with excellent antiviral efficacy for the oseltamivir-resistant virus (EC50= 0.021 to 0.040 uM), may target viral ribonucleoproteins (RNPs) for viral RNA synthesis, also inhibits SARS-CoV-2 RNA-dependent RNA polymerase (RdRp) with IC50 of 4.6 uM. |
| PC-24187 |
Suraxavir marboxil
Infuenza PA Inhibitor
|
Suraxavir marboxil (GP681) is an orally bioavailable antiviral drug inhibiting the polymerase acidic protein (PA) of RNA polymerase of influenza virus, demonstrates nanomolar antiviral activity against both influenza A and B viruses with the average IC50 on the transcriptional activity of 0.6 nM, EC90 of 6.9 ng/mL. |
| PC-22714 |
Compound J1
Hemagglutinin inhibitor
|
Compound J1 is a small molecule compound targeting hemagglutinin (HA), inhibits influenza A virus and exhibits broad-spectrum antiviral activity against SARS-CoV-2, HSV1 and HSV2. |
| PC-22660 |
AV5116
Influenza virus inhibitor
|
AV5116 is a structural analogue of influenza virus endonuclease inhibitor baloxavir, and cap-dependent endonuclease (CEN) inhibitor. |
| PC-22659 |
AV5115
Influenza virus inhibitor
|
AV5115 is a structural analogue of influenza virus endonuclease inhibitor baloxavir, and cap-dependent endonuclease (CEN) inhibitor. |
| PC-20584 |
MBX2546
Influenza virus HA inhibitor
|
MBX2546 is a small molecule inhibitor of influenza virus via targeting influenza hemagglutinin (HA), specifically inhibits HA-mediated viral entry with potent antiviral activity against different influenza virus strains (IC50=0.3-5.9 uM). |
